Sea Mild Biotechnology Co., Ltd. (TPEX:7516)
Taiwan · Delayed Price · Currency is TWD 9.35
+0.05 (0.54%)
Jun 3, 2026, 1:52 PM CST
Sea Mild Biotechnology Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 341.94 | 318.82 | 257.02 | 202.65 | 163.82 | |
Revenue Growth (YoY) | 7.25% | 24.05% | 26.83% | 23.71% | -21.20% |
Cost of Revenue | 252.74 | 227.54 | 200.65 | 166.49 | 144.73 |
Gross Profit | 89.2 | 91.28 | 56.37 | 36.16 | 19.09 |
Selling, General & Admin | 75.82 | 64.49 | 48.15 | 45.21 | 47.72 |
Research & Development | 6.16 | 4.52 | 3.38 | 2.97 | 4.9 |
Operating Expenses | 81.98 | 69 | 51.54 | 48.14 | 51.08 |
Operating Income | 7.22 | 22.28 | 4.83 | -11.98 | -31.99 |
Interest Expense | -2.46 | -1.26 | -0.97 | -0.68 | -0.83 |
Interest & Investment Income | 0.6 | 0.44 | 0.3 | 0.08 | 0.11 |
Currency Exchange Gain (Loss) | 0 | 0.18 | -0.07 | 0.13 | -0.13 |
Other Non Operating Income (Expenses) | 2.75 | 3.34 | 0.95 | 0.07 | -2.45 |
EBT Excluding Unusual Items | 8.11 | 24.97 | 5.04 | -12.38 | -35.3 |
Gain (Loss) on Sale of Assets | 0.23 | - | 0.28 | -0.11 | 3.3 |
Asset Writedown | - | 7.97 | - | -9 | -10 |
Other Unusual Items | 0.46 | - | 0.81 | 0.01 | - |
Pretax Income | 8.79 | 32.94 | 6.13 | -21.48 | -42 |
Income Tax Expense | -0.05 | 0.95 | -0.06 | -0.1 | 10.06 |
Earnings From Continuing Operations | 8.84 | 31.99 | 6.19 | -21.38 | -52.05 |
Net Income | 8.84 | 31.99 | 6.19 | -21.38 | -52.05 |
Net Income to Common | 8.84 | 31.99 | 6.19 | -21.38 | -52.05 |
Net Income Growth | -72.37% | 417.02% | - | - | - |
Shares Outstanding (Basic) | 19 | 19 | 19 | 19 | 19 |
Shares Outstanding (Diluted) | 19 | 19 | 19 | 19 | 19 |
EPS (Basic) | 0.46 | 1.66 | 0.32 | -1.11 | -2.70 |
EPS (Diluted) | 0.46 | 1.66 | 0.32 | -1.11 | -2.70 |
EPS Growth | -72.37% | 417.70% | - | - | - |
Free Cash Flow | -7.39 | 22.97 | 7.59 | 11.71 | -15.2 |
Free Cash Flow Per Share | -0.38 | 1.19 | 0.39 | 0.61 | -0.79 |
Gross Margin | 26.09% | 28.63% | 21.93% | 17.84% | 11.65% |
Operating Margin | 2.11% | 6.99% | 1.88% | -5.91% | -19.53% |
Profit Margin | 2.58% | 10.03% | 2.41% | -10.55% | -31.77% |
Free Cash Flow Margin | -2.16% | 7.20% | 2.95% | 5.78% | -9.28% |
EBITDA | 17.86 | 28.12 | 7.38 | -7.74 | -21.99 |
EBITDA Margin | 5.22% | 8.82% | 2.87% | -3.82% | -13.42% |
D&A For EBITDA | 10.64 | 5.84 | 2.55 | 4.24 | 10 |
EBIT | 7.22 | 22.28 | 4.83 | -11.98 | -31.99 |
EBIT Margin | 2.11% | 6.99% | 1.88% | -5.91% | -19.53% |
Effective Tax Rate | - | 2.88% | - | - | - |